Neurological HIV-related disorders;HIV-assoziierte neurologische erkrankungen

Aktuelle Neurologie

Volumn 26, Issue 8, 1999, Pages 349-359

  Maschke, Matthias ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; SELEGILINE; ZIDOVUDINE;

BRAIN INFECTION; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROLOGIC DISEASE; REVIEW; VIRUS DETECTION; VIRUS LOAD;

EID: 0033372995     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017650     Document Type: Review

References (83)

1. Gabuzda, D. H., M. S. Hirsch: Neurologic manifestations of infection with human immunodeficiency virus: clinical features and pathogenesis. Ann. Intern. Med. 107 (1987) 383-391
2. Janssen, R. S.: Epidemiology and neuroepidemiology of human immunodeficiency virus infection. In: Berger, J. R., R. M. Levy (eds.): AIDS and the Nervous System. Second Edition. Lippincott-Raven, Philadelphia (1997) 13-37
3. Levy, R. M., D. E. Bredesen, M. L. Rosenblum: Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J. Neurosurg. 15 (1985) 475-495
4. Maschke, M., H. C. Diener: Neurologische HIV-Erkrankung. In: Psychrembel Therapeutisches Wörterbuch. De Gruyter, Berlin, New York (1998) 293-295
5. Koenig, S., H. E. Gendelman, J. M. Orenstein et al.: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233 (1986) 1089-1093
6. Michaels, J, L. R. Sharer, L. G. Epstein: Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immundefic. Rev. 1 (1988) 71-104
7. Nottet, H. S., Y. Persidsky, V. G. Sasseville et al.: Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156 (1996) 1284
8. Wiley, C. A., R. D. Schrier, J. A. Nelson et al.: Cellular localization of human immunodeficiency virus within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83 (1986) 7089-7093
9. Tyor, W. R., J. D. Glass, J. W. Griffin et al.: Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31 (1992) 349-360
10. Wesseling, S. L., J. D. Glass, J. W. Griffin et al.: Intracerebral cytokine expression during AIDS. Ann. Neurol. 33 (1993) 576-589
11. Dal Pan, G. J., J. C. McArthur, M. J. G. Harrison: Neurological symptoms in human immunodeficiency virus infection. In: Berger, J. R., R. M. Levy (eds.): AIDS and the nervous system. Second Edition. Lippincott-Raven, Philadelphia (1997) 141-172
12. Guiloff, R. J., R. Malessa , H. W. Pfister: Human immunodeficiency virus infections - neurological manifestations. In: Brandt, T., L. R. Caplan, J. Dichgans et al. (eds.) Neurological disorders. Academic Press, San Diego (1996) 455-476
13. Mertens, T. E., D. Low-Beer: HIV and AIDS: where is the epidemic going? Bull. WHO 74 (1996) 121-129
14. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122 (1995) 573-579
15. Mellors, J. W., A. Munoz, J. V. Giorgi et al.: Plasma viral load and CD4+lymphocytes as prognostic markers of HIV-infection. Ann. Intern. Med. 126 (1997) 946-954
16. Saag, M. S., M. Holodniy, D. R. Kuritzkes et al.: HIV viral load markers in clinical practice. Nat. Med. 2 (1996) 625-629
17. Schooley, R. T.: Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 9, Suppl. 2 (1995) 15-19
18. Centers of Disease Control: 1993 revised classification system for HIV-infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (1992) 1-19
19. Bacellar, H., A. Munoz, E. N. Miller et al.: Temporal trends in the incidence of HIV-1-related neurologic diseases: Mulitcenter AIDS cohort study. Neurology 44 (1992) 1892-1900
20. Centers of Disease Control and Prevention: HIV/AIDS surveillance report. 7 (1995) 1-39
21. Brodt, H. R., B. S. Kamps, P. Gute et al.: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11 (1997) 1731-1738
22. th Conference on Retroviruses and Opportunistic Infections. Chicago, 1.2.-5.2. 1998
23. Takahashi, K., S. L. Wesselingh, J. W. Griffin et al.: Localization of HIV-1 in human brain using polymerase chain reaction in situ hybridization and immunocytochemistry. Ann. Neurol. 39 (1996) 705
24. Yeung, M. C., L. Pulliam, A. S. Lau: The HIV envelope protein gp 120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor. AIDS 9 (1995) 137-143
25. Epstein, L. G., H. E. Gendelman: Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33 (1993) 429-436
26. Price, R. W., B. Brew, J. Sidtis et al.: The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239 (1988) 586-592
27. Dreyer, E. B., P. K. Kaiser, J. T. Offermann et al.: HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248 (1990) 364-367
28. Lipton, S. A.: Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor mediated neurotoxicity. Ann. Neurol. 33 (1993) 227-228
29. Sasseville, V. G., W. A. Newman, A. A. Lackner et al.: Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141 (1992) 1021-1030
30. Navia B. A., B. D. Jordan, R. W. Price: The AIDS dementia complex. I. Clinical features. Ann Neurol 19 (1986) 517-524
31. Snider, W. D., D. M. Simpson, S. Nielsen et al.: Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann. Neurol. 14 (1983) 403-418
32. Power, C, O. A. Seines, J. A. Grim, J. C. McArthur: The HIV dementia scale: a rapid screening test. J. AIDS 8 (1995) 273-278
33. Arendt G., H. Hefter, E. Neuen-Jacob et al.: Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia. J. Neurol. 240 (1993) 439-445
34. Arendt, G., H. P. Maecker, J. Purrmann et al.: Control of posture in patients with neurologically asymptomatic HIV infection and patients with beginning HIV-1 related encephalopathy. Arch. Neurol. 51 (1994) 1232-1235
35. Price, R. W., B. Brew: The AIDS dementia complex. J. Infect. Dis. 158 (1988) 1079-1083
36. McArthur, J. C., E. Sipos, D. R. Cornblath et al.: Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 39 (1989) 66-70
37. Brew, B. J., R. B. Bhalla, M. Paul et al.: Cerebrospinal fluid neopterin in human immunodeficiency virus type-1 infection. Ann. Neurol. 28 (1990) 556-560
38. Brew, B. J., R. B. Bhalla, M. Paul et al.: Cerebrospinal fluid ß-2 microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS 6 (1992) 461-465
39. Heyes, M. P., B. J. Brew, A. Martin et al.: Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurologic status. Ann. Neurol. 29 (1991) 202-209
40. Malessa, R., M. Heimbach, N. H. Brockmeyer et al.: Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV-encephalopathy. J. Neurol. Sci. 136 (1996) 154-159
41. Brew, B. J., L. Pemberton, P. Cunnigham et al.: Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 175 (1997) 963-966
42. Hengge, U. R., N. H. Brockmeyer, S. Esser et al.: HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia. AIDS 12 (1998) 818-820
43. Levy, R. M., S. Rosenbloom, L. V. Perrett: Neuroradiologic findings in AIDS: a review of 200 cases. Am. J. Roentgenol. 147 (1986) 977-983
44. Portegies, P., R. H. Enting, J. deGans et al.: Presentation and course of AIDS dementia complex: ten years of follow-up in Amsterdam, the Netherlands. AIDS 7 (1993) 669-675
45. Heindel, W. C., S. L. Archibald, C. L. Achim et al.: The relationship of quantitative brain magnetic resonance imaging measures to neuropathological indices of HIV infection. Arch. Neurol. 51 (1994) 1129-1135
46. Jernigan, T. L., S. L. Archibald, M. T. Berhow et al.: MRI morphometric analysis of cerebral volume loss in HIV infection. Arch. Neurol. 50 (1993) 250-255
47. Rottenberg, D. A., J. R. Moeller, S. C. Strother et al.: The metabolic pathology of the AIDS dementia complex. Ann. Neurol. 22 (1987) 700-706
48. Saktor, N., R. van Heertum, G. Doonief et al.: A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment. Arch. Neurol. 52 (1995) 1170-1173
49. Schielke, E., K. Tatsch, H. W. Pfister et al.: Reduced cerebral blood flow in early stages of HIV infection. Arch. Neurol. 47 (1990) 1342-1345
50. Barker, P. B., R. R. Lee, J. C. McArthur: AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 195 (1995) 58-64
51. Holman, B., B. Garada, K. Johnson et al.: A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J. Nucl. Med. 33 (1992) 1312-1315
52. Harden, C. L., M. Daras, A. J. Tuchman et al.: Low amplitude EEG's in demented AIDS patients. EEG Clin. Neurophysiol. 87 (1993) 54-56
53. Portegies, P., J. deGans, J. M. Lange et al.: Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 299 (1989) 819-821
54. Rolinski, B., J. R. Bogner, I. Sadri, U. et al.: Absorption annd elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients. J AIDS Hum Retrovirol 15 (1997) 192-197
55. Sacktor, N. C., J. C. McArthur: Prospects for therapy of HIV-associated neurologic disease. J. Neurovirol. 3 (1997) 89-101
56. Sidtis J. J., C. Gatsonis, R. W. Price et al.: Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann. Neurol. 33 (1993) 343-349
57. Tozzi, V., P. Narciso, S. Galgani et al.: Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex. AIDS 7 (1993) 683-692
58. Sidtis J. J., U. Dafni, P. Slasor et al.: Stable neurological function in subjects treated with 2'3'-dideoxyinosine. J. Neurovirol. 3 (1997) 233-240
59. Navia B. A., U. Dafni, D. Simpson et al.: A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 51 (1998) 221-228
60. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders: Double-blind, placebo-controlled trial of deprenyl and thioctic acid in HIV-associated cognitive impairment. Neurology 50 (1998) 645-651
61. Bouwman, F. H., R. L. Skolasky, D. Hes et al.: Variable progression of HIV-associated dementia. Neurology 50 (1998) 1814-1820
62. McArthur, J. C., R. Skolasky, G. Dal Pan et al.: Variation in clinical progression with HIV-associated dementia. In: Neuroscience of HIV-Infection: basic and clinical frontiers. Vancouver, British Columbia, 2.-4. August, 1994
63. Dal Pan, G. J., J. D. Glass, S. Zeidman et al.: Clinicopathologic correlations of HIV-associated vacuolar myelopathy: an autopsy-based case-control study. Neurology 44 (1994) 2159-2164
64. Oksenhendler, E., F. Ferchal, J. Cadranel et al.:Zidovudine for HIV-related myelopathy. Am. J. Med. 88 (1990) 565-566
65. Barohn, R. J., G. S. Gronseth, B. R. LeForce et al.: Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch. Neurol. 50 (1993) 167-171
66. So, Y. T., D. M. Holtzman, D. J. Abrams et al.: Peripheral neuropathy associated with acquired immunodeficiency syndrome: prevalence and clinical features from a population-based survey. Arch. Neurol. 45 (1988) 945-948
67. Apostolski, S., T. McAlarney, A. Quattrini et al.: The gp120 glykoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann. Neurol. 34 (1993) 855-863
68. Griffin, J. W., S. Wesselingh, A. L. Oaklander: mRNA fingerprinting of cytokines and growth factors: a new means of characterizing nerve biopsies (abstract). Neurology 43, Suppl. 2 (1993) A232
69. Yoshioka, M., P. Shapshak, A. K. Srivasta et al.: Expression of HIV-1 and Interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44 (1994) 1120-1130
70. deGans, J., P. Portegies, G. Tiessens et al.: Therapy for cytomegalovirus polyradiculopathy in patients with AIDS. Treatment with ganciclovir. AIDS 4 (1990) 421-425
71. Said, G., C. Lacroix, P. Chemouilli et al.: Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann. Neurol. 29 (1991) 139-146
72. Berger, A. R., J. C. Arezzo, H. H. Schaumburg et al.: 2'3'-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43 (1993) 358-362
73. Kieburtz, K. D., M. Seidlin, J. S. Lambert et al.: Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J. AIDS 5 (1992) 60-64
74. Browne, M. J., K. H. Mayer, S. B. Chafee et al.: 2'3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J. Infect. Dis. 167 (1993) 21-29
75. Ghika-Schmid, F., T. Kuntzer, J. P. Chave et al.: Diversite de l'atteinte neuromusculaire de 47 patients infectes par le virus de l'immundeficience humaine. Schweiz. Med. Wochenschr. 124 (1994) 791-800
76. Miller, R. G., C. J. Parry, M. W. Pfae et al.: The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 11 (1988) 857-863
77. Roullet, E., V. Assuerus, J. Gozlan et al.: Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive patients. Neurology 44 (1994) 2174-2182
78. Kim, Y. S., H. Hollander: Polyradiculopathy due to cytomegalovirus: Report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin. Infect. Dis. 17 (1993) 32-37
79. Simpson, D. M., D. Dorfman, R. K. et al.: Peptide T in the treatment of painful distal neuropathy associated with AIDS. Neurology 47 (1996) 1254-59
80. Kieburtz, K. D., C. Yiannoutsos, D. Simpson, and the ACTG 242 Team: A double-blind randomized clinical trial of amitripytline and mexiletine for painful neuropathy in HIV-infection. Ann. Neurol. 42 (1997) 429
81. Dalakas, M. C., G. H. Pezeshkpour, M. Gravekk et al.: Polymyositis associated with AIDS virus. JAMA 256 (1986) 2381-2383
82. Simpson, D. M., J. Godbold, S. Hassett et al.: HIV-associated myopathy and the effects of zidovudine and prednisone. Clin. Neuropathol. 12 (1993) S20
83. Peters, B., G. Wilson, A. Pinching: Zidovudin myopathy. A prospective study. Proceedings of Vth International Conference on AIDS, Montreal (1989) 266